Leu Agelii M, Lehtinen-Jacks S, Zetterberg H, Sundh V, Björkelund C, Lissner L
Section for Epidemiology and Social Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Section for Epidemiology and Social Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Faculty of Social Sciences, Health Sciences, University of Tampere, Tampere, Finland.
Nutr Metab Cardiovasc Dis. 2017 Dec;27(12):1143-1151. doi: 10.1016/j.numecd.2017.10.013. Epub 2017 Oct 25.
The impact of vitamin D concentrations on subsequent cardiovascular disease (CVD) and overall mortality has been generally examined for periods under two decades. The magnitude of the association may depend on follow-up length. We aimed to investigate the relationship between baseline vitamin D and risk of total CVD, stroke and all-cause mortality over three decades of follow-up. Secondly, we aimed to assess how follow-up affects the associations.
Concentrations of 25-hydroxyvitamin D (25D) were measured in a population-based sample of 1227 middle-aged women using serum collected at baseline and categorized into low (lowest 25D quartile) vs high 25D status (upper three 25D quartiles). Hazard ratio (HR) of the endpoints was estimated for low 25D. The impact of follow-up was examined in intermediary analyses where follow-up was interrupted up to four times, each time decreasing it by five years. There were 596 cardiovascular events and 635 participants died. During the first 17 years, the low 25D group experienced a 29% higher CVD risk and 3.3-fold higher stroke risk after accounting for confounders. Longer follow-up diminished significantly these risks and 25D status had no contribution at 32 years. For mortality, the decline over time was less dramatic, with HR = 1.96 (1.25; 3.08) at 17 years and HR = 1.42 (1.17; 1.72) at 37 years.
Low 25D status increased the risk for all endpoints, but a lengthy follow-up diminished these risks towards the null. The impact of follow-up depends on the outcome. Future studies of 25D and disease should use repeated 25D assessments.
维生素D浓度对后续心血管疾病(CVD)及全因死亡率的影响通常在不到二十年的时间段内进行研究。这种关联的强度可能取决于随访时长。我们旨在研究基线维生素D与三十年随访期内总CVD、中风风险及全因死亡率之间的关系。其次,我们旨在评估随访如何影响这些关联。
在一个基于人群的1227名中年女性样本中,使用基线时采集的血清测量25-羟基维生素D(25D)浓度,并将其分为低25D状态(最低的25D四分位数)和高25D状态(较高的三个25D四分位数)。估计低25D状态下终点事件的风险比(HR)。在中间分析中检验随访的影响,其中随访最多中断四次,每次减少五年。发生了596例心血管事件,635名参与者死亡。在最初的17年中,在考虑混杂因素后,低25D组的CVD风险高29%,中风风险高3.3倍。更长时间的随访显著降低了这些风险,在32年时25D状态没有影响。对于死亡率,随时间的下降不太明显,17年时HR = 1.96(1.25;3.08),37年时HR = 1.42(1.17;1.72)。
低25D状态增加了所有终点事件的风险,但长时间的随访使这些风险趋近于零。随访的影响取决于结局。未来关于25D与疾病的研究应使用重复的25D评估。